Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Avanos Medical (AVNS) Tax Provisions (2016 - 2026)

Avanos Medical's Tax Provisions history spans 13 years, with the latest figure at $2.5 million for Q4 2025.

  • On a quarterly basis, Tax Provisions rose 110.64% to $2.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.7 million, a 139.41% increase, with the full-year FY2025 number at $6.7 million, up 139.41% from a year prior.
  • Tax Provisions hit $2.5 million in Q4 2025 for Avanos Medical, up from $200000.0 in the prior quarter.
  • Over the last five years, Tax Provisions for AVNS hit a ceiling of $38.0 million in Q3 2021 and a floor of -$46.0 million in Q2 2021.
  • Historically, Tax Provisions has averaged -$555000.0 across 5 years, with a median of $1.4 million in 2022.
  • Biggest five-year swings in Tax Provisions: plummeted 1486.21% in 2021 and later soared 788.89% in 2023.
  • Tracing AVNS's Tax Provisions over 5 years: stood at $2.6 million in 2021, then surged by 76.92% to $4.6 million in 2022, then tumbled by 145.65% to -$2.1 million in 2023, then plummeted by 1019.05% to -$23.5 million in 2024, then surged by 110.64% to $2.5 million in 2025.
  • Business Quant data shows Tax Provisions for AVNS at $2.5 million in Q4 2025, $200000.0 in Q3 2025, and $900000.0 in Q2 2025.